All Outputs (5)

Rapid Eczema Trials: Addressing patient priorities from the eczema priority setting partnership (2024)
Journal Article
Campbell, E. L., Fong, W. C. G., Roberts, A., & Thomas, K. S. (2024). Rapid Eczema Trials: Addressing patient priorities from the eczema priority setting partnership. British Journal of Dermatology, Article ljae362. https://doi.org/10.1093/bjd/ljae362

In this letter, we describe the Rapid Eczema Trials co-production project, which aims to plug some of the research gaps that remain following the 2011 James Lind Alliance Eczema Priority Setting Partnership (PSP) exercise. We highlight similarities b... Read More about Rapid Eczema Trials: Addressing patient priorities from the eczema priority setting partnership.

Time for a proper career pathway for clinical trial managers? (2023)
Journal Article
Mitchell, E. J., Campbell, E., Goodman, K., Taylor, J., Youssouf, N. F. J., & Wakefield, N. (2023). Time for a proper career pathway for clinical trial managers?. Trials, 24(1), Article 565. https://doi.org/10.1186/s13063-023-07598-1

Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials (2023)
Journal Article
Rahman, R., Janowski, M., Killick-Cole, C. L., Singleton, W. G. B., Campbell, E., Walczak, P., Khatua, S., Faltings, L., Symons, M., Schneider, J. R., Kwan, K., Boockvar, J. A., Gill, S. S., Miguel Oliveira, J., Beccaria, K., Carpentier, A., Canney, M., Pearl, M., Veal, G. J., Meijer, L., & Walker, D. A. (2023). Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials. Cancers, 15(3), Article 857. https://doi.org/10.3390/cancers15030857

Brain and spinal tumors affect 1 in 1000 people by 25 years of age, and have diverse histological, biological, anatomical and dissemination characteristics. A mortality of 30–40% means the majority are cured, although two-thirds have life-long disabi... Read More about Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials.

EPCT-03. Working together to accelerate the preclinical to clinical translation of drug delivery systems for children’s brain tumours (2022)
Presentation / Conference Contribution
Campbell, E., Aquilina, K., Dandapani, M., Walker, D., & Rahman, R. EPCT-03. Working together to accelerate the preclinical to clinical translation of drug delivery systems for children’s brain tumours

Children's brain tumours are the biggest cancer killer in children and young adults. Several techniques, such as intra-cerebrospinal fluid chemotherapy, ultrasound-mediated blood-brain barrier disruption, convection enhanced delivery, polymer deliver... Read More about EPCT-03. Working together to accelerate the preclinical to clinical translation of drug delivery systems for children’s brain tumours.

Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey (2014)
Journal Article
Smyth, A. R., & Campbell, E. L. (2014). Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey. Journal of Cystic Fibrosis, 13(4), https://doi.org/10.1016/j.jcf.2013.11.007

Background: Intravenous aminoglycoside antibiotics are widely used to treat pulmonary infection with Pseudomonas aeruginosa in individuals with cystic fibrosis (CF). Over the last decade evidence has accumulated showing that the choice of aminoglycos... Read More about Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey.